Shan Dong Kexing Bioproducts Co (SHSE:688136) Retained Earnings: ¥253 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688136 Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
46 GF Score
Price ¥20.56
GF Value ¥24.52
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shan Dong Kexing Bioproducts Co Retained Earnings?

Shan Dong Kexing Bioproducts Co SHSE:688136 -0.96% 46 Retained Earnings is ¥253 Mil as of Mar. 2026. GuruFocus rates SHSE:688136 with a GF Score™ of 46/100 and a GF Value™ of ¥24.52 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shan Dong Kexing Bioproducts Co's retained earnings for the quarter that ended in Mar. 2026 was ¥253 Mil.

Shan Dong Kexing Bioproducts Co's quarterly retained earnings increased from Sep. 2025 (¥247 Mil) to Dec. 2025 (¥271 Mil) but then declined from Dec. 2025 (¥271 Mil) to Mar. 2026 (¥253 Mil).

Shan Dong Kexing Bioproducts Co's annual retained earnings increased from Dec. 2023 (¥125 Mil) to Dec. 2024 (¥152 Mil) and increased from Dec. 2024 (¥152 Mil) to Dec. 2025 (¥271 Mil).


Shan Dong Kexing Bioproducts Co  (SHSE:688136) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shan Dong Kexing Bioproducts Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for Shan Dong Kexing Bioproducts Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shan Dong Kexing Bioproducts Co Retained Earnings Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only 425.91 315.74 125.45 151.83 270.70

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.41 216.39 247.31 270.70 252.77
SHSE:688136
46GF Score
Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shan Dong Kexing Bioproducts Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of ¥253 Mil mean?
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a Retained Earnings of ¥253 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shan Dong Kexing Bioproducts Co and its competitors.
Is Shan Dong Kexing Bioproducts Co's Retained Earnings too high?
Shan Dong Kexing Bioproducts Co's current Retained Earnings is ¥253 Mil. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's Retained Earnings compare to VRTX and REGN?
Shan Dong Kexing Bioproducts Co's Retained Earnings of ¥253 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. Shan Dong Kexing Bioproducts Co's current Retained Earnings is ¥253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.52, compared to a current price of ¥20.56 — trading 16.2% below its estimated fair value. The current Retained Earnings is ¥253 Mil. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current Retained Earnings is ¥253 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?

Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued. The current stock price of ¥20.56 is trading 16.2% below its estimated GF Value™ of ¥24.52. GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.

Key valuation signals for SHSE:688136:

  • Retained Earnings: ¥253 Mil
  • GF Value™: ¥24.52 vs. price of ¥20.56 (16.2% below fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shan Dong Kexing Bioproducts Co Business Description

Address No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
46GF Score

Get the complete analysis for SHSE:688136

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.56
Price
¥24.52
GF Value